Nucleic Acid Drugs in Radiotherapy

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy

Background:

• Radiotherapy is a key cancer treatment that uses radiation to kill tumor cells.
• Challenges like radiation resistance and side effects limit radiotherapy's effectiveness.
• Nucleic acid drugs (NADs) offer a novel approach to overcome these limitations.

Purpose of the Study:

• To review the role of nucleic acid drugs (NADs) in optimizing cancer radiotherapy.
• To explore the mechanisms, clinical applications, and synergistic potential of NADs with radiotherapy.
• To highlight NADs as a promising strategy for improving cancer treatment outcomes.

Main Methods:

• Literature review of studies on nucleic acid drugs and radiotherapy.
• Analysis of NADs' mechanisms in targeting DNA repair and tumor hypoxia.
• Examination of NADs as delivery vehicles for radiotherapy agents.
• Exploration of clinical applications and synergistic effects.

Main Results:

• NADs can enhance radiotherapy sensitivity by targeting key cancer pathways.
• NADs can act as delivery systems for radionuclides, improving precision and reducing side effects.
• NADs demonstrate potential in overcoming radiation resistance.

Conclusions:

• Nucleic acid drugs show significant promise for enhancing radiotherapy efficacy.
• NADs offer a versatile strategy for improving cancer treatment outcomes.
• Further research into NADs' clinical applications is warranted.